Shanghai Haohai Biological Technology Co Ltd (fra:5HB) Share Price

Company Profile

Business description
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
Contact
No. 1386 Hongqiao Road
23rd Floor, WenGuang Plaza
Changning District
Shanghai
CHN
T: +86 2152293555
https://www.3healthcare.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,110

Recommended

AI is reshaping ASX tech moats - but some are more insulated than others.

Tyger Fitzpatrick | 22 March 2026

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.

Dan Romanoff, CPA | 20 March 2026

Sims guides huge earnings upgrade as data center metals demand spikes.

Esther Holloway | 20 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,552.60	110.50	-1.28%
CAC 40	7,511.59	154.03	-2.01%
DAX 40	21,893.00	487.19	-2.18%
Dow JONES (US)	45,577.47	443.96	-0.96%
FTSE 100	9,686.63	376.87	-3.74%
HKSE	24,382.47	1,118.11	-4.38%
NASDAQ	21,647.61	443.08	-2.01%
Nikkei 225	51,515.49	1,857.04	-3.48%
NZX 50 Index	12,899.72	151.89	-1.16%
S&P 500	6,506.48	100.01	-1.51%
S&P/ASX 200	8,365.90	106.40	-1.26%
SSE Composite Index	3,813.28	143.77	-3.63%